在牛皮关节炎中多种b/tsDMARD失败的负担和决定因素
Rebecca H Haberman1, Kyra Chen2, Catherine Howe2
1Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA. Rebecca.Haberman@nyulangone.org.
Arthritis research & therapy
|March 4, 2025
概括
许多牛皮关节炎患者在多种治疗中失败. 女性性别,肥胖,轴性疾病和抑郁症与治疗失败有关,这表明需要个性化牛皮关节炎疗法.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮关节炎 (PsA) 治疗方法已经进步,但许多患者没有达到缓解.
- 使用生物 (b) -或向合成 (ts) -疾病修饰性抗风湿药物 (DMARDs) 的重复性治疗失败是PsA管理中的一个重大挑战.
- 了解多种药物失效的原因对于改善患者的治疗结果至关重要.
研究的目的:
- 描述PsA患者经历多药失败的处方模式.
- 为了确定与多b/tsDMARD在PSA失败相关的患者特征.
- 调查导致牛皮关节炎重复治疗失败的风险因素.
主要方法:
- 使用了960名PsA患者的纵向观察注册.
- 收集的数据包括人口统计,病史,药物使用和疾病表型.
- 多个b/tsDMARD的失败被定义为需要四个或更多的b/tsDMARD.
主要成果:
- 17%的PsA患者 (166/960) 经历了多种b/tsDMARD失败.
- 多种药物失效的危险因素包括女性性别,轴性疾病,抑郁症和肥胖.
- 多种药物失效的患者表现出更高的疾病活性,包括增加的胀关节数量.
结论:
- 多种b/tsDMARD失败影响了大量的PsA患者.
- 女性性别,肥胖,轴心干扰和抑郁症与更高的治疗失败率有关.
- 这些发现强调了需要精准医学和辅助疗法来提高牛皮关节炎治疗结果的必要性.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Autoimmune Disorders
377
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
377
Drug Therapy
34
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
34


